Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.

authors

  • Eddine O. Kacimi Salah
  • Dehais Caroline
  • Feuvret Loic
  • Chinot Olivier
  • Carpentier Catherine
  • Bronnimann Charlotte
  • Vauléon Elodie
  • Djelad Apolline
  • L. Cohen-Jonathan Moyal Elizabeth
  • Langlois Olivier
  • Campone Mario
  • Ducloie Mathilde
  • Noel Georges
  • Cuzzubbo Stefania
  • Ricard Damien
  • Faillot Thierry
  • Boëlle Pierre-Yves
  • Figarella‑branger Dominique
  • Ducray François
  • Touat Mehdi

more information